Prostate Cancer Biopsy, Diagnoses Down During the Pandemic
However, there were no statistically significant changes in rates by race.
However, there were no statistically significant changes in rates by race.
The phase 3 MAGNITUDE study assessed niraparib in combination with abiraterone acetate plus prednisone in patients with mCRPC with or without alterations in homologous recombination repair associated genes.
Researchers used 2018 data from the National Health Interview Survey to investigate the association.
Equal access to care may not be sufficient to eliminate racial and ethnic disparities in prostate cancer care, according to investigators.
A study of patients with localized prostate cancer showed that 13% reported treatment-related regret.
Finding from a recent study could be used in patient counseling to promote healthier lifestyle choices to reduce the likelihood of prostate biopsy, according to investigators.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.
The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry.
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.